LRRK2 and Parkinson disease: This may be important in regard to the treatment of PD and/or understanding the mechanism of action of LRRK2 kinase inhibitors, particularly as recent rodent29,42,50 and clinical51–53 studies support an important role for peripheral myeloid cells in PD pathogenesis.